Press Room - Sanofi US News

Menu

Media Room Menu

Month Year

Month Year

Nov 8, 2015

Sanofi and Regeneron Present Results from Pivotal Phase 3 Study of Sarilumab at American College of Rheumatology Annual Meeting

- Data Show Significant Improvement in Signs and Symptoms and Physical Function in Rheumatoid Arthritis Patients who were Inadequate Responders to or Intolerant of TNF-Alpha Inhibitors (TNF-IR) -
Nov 5, 2015

Sanofi and Regeneron to Present Results from Phase 3 Praluent® (alirocumab) Injection Clinical Trials at AHA Scientific Sessions 2015
Oct 30, 2015

UPDATED: Sanofi US Issues Voluntary Nationwide Recall of All Auvi-Q® Due to Potential Inaccurate Dosage Delivery
- Photos 1
Sep 28, 2015

Sanofi Reaches Patent Settlement on Lantus® SoloSTAR®
- Photos 1
Aug 31, 2015

Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes

- Will work together on new digital technology and tools for diabetes -
- Photos 1

Show per page

Print
Email page
RSS

You are about to leave www.sanofi.us

If you wish to continue to this external website, click Proceed. It is provided for information only. Sanofi assumes no responsibility for the information presented on this website.